News Releases | Lexicon Pharmaceuticals, Inc.

Press Releases

Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Clinical Update	Mar 10, 2021
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-year 2020 Financial Results Conference Call and Webcast on March 10, 2021	Mar 04, 2021
Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure	Jan 14, 2021
Lexicon Pharmaceuticals to Participate in the 39th Annual J.P. Morgan Healthcare Conference	Jan 06, 2021
Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia	Dec 31, 2020
Lexicon Pharmaceuticals Enters Data Collaboration with AC Bioscience	Dec 16, 2020
Lexicon Announces Offering of Common Stock	Dec 11, 2020
Lexicon Pharmaceuticals Receives Fast Track Designation from the FDA for LX9211 for Diabetic Peripheral Neuropathic Pain	Dec 11, 2020
Results from Soloist and Scored Outcomes Studies Presented at Late-breaking Science Session of American Heart Association Scientific Sessions and Published in the New England Journal of Medicine	Nov 16, 2020
Lexicon Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference	Nov 16, 2020